hidocdr.com Open in urlscan Pro
18.245.60.78  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Journal|Articles|News|Quizzes|Webinars|Conferences|About us
Join as KOL

--------------------------------------------------------------------------------

Hidoc Dr. (Global)

Hidoc MediBot: Virtual Assistant for Medical-Related Queries

Ask Query
Ask Query

Fastest Growing Medical Platform for Doctors

Total Monthly Active HCPs: 1.3M+

Today's News


 * OREXIN AGONIST TAK-861 SHOWS PRONOUNCED EFFECTS IN PHASE 2B TRIAL OF
   NARCOLEPSY TYPE 1
   
   Published Date: 20 Jun 2024
   
   Across both the primary and secondary end points, treatment with TAK-861
   resulted in significant improvements in symptom severity among patients with
   narcolepsy type 1.


 * FDA CLEARS PHASE 1/2 CLINICAL TRIAL FOR SPINOGENIX’S ALS TREATMENT SPG302
   
   Published Date: 20 Jun 2024
   
   The cleared phase 1/2 clinical trial will assess SPG302 as a once-a-day pill
   among patients with amyotrophic lateral sclerosis.


 * PEDIATRIC PALLIATIVE CARE: WHAT THE GENERAL PEDIATRICIAN NEEDS TO KNOW
   
   Published Date: 20 Jun 2024
   
   Get to know the essentials of pediatric palliative care.


 * WEEKLY REVIEW: NEW FDA APPROVALS FOR T2D, PJIA, AND MORE
   
   Published Date: 20 Jun 2024
   
   Get caught up with our journal! Review some of the top stories from the
   Contemporary Pediatrics website over the last week, and catch up on anything
   you may have missed.


 * ONABOTULINUMTOXINA SHOWS PROMISE FOR TREATING CHRONIC MIGRAINE
   
   Published Date: 20 Jun 2024
   
   Approximately half of study participants had tried lifestyle modifications
   and used vitamin supplementation, and most were taking multiple medications.


 * SURVEY: MOST PARENTS BELIEVE SCHOOLS SHOULD HAVE A MENTAL HEALTH PROFESSIONAL
   
   Published Date: 20 Jun 2024
   
   The national survey revealed parents are eager to learn more about
   school-based mental health services.


 * REAL-WORLD EXPERIENCES WITH AFLIBERCEPT 8MG
   
   Published Date: 20 Jun 2024
   
   Experts share their real-world experience with aflibercept 8 mg, comparing it
   to its predecessor, aflibercept 2 mg.


 * NEUROLOGYLIVE® BRAIN GAMES: JUNE 16, 2024
   
   Published Date: 20 Jun 2024
   
   Test your neurology knowledge with NeurologyLive®'s weekly quiz series,
   featuring questions on a variety of clinical and historical neurology topics.
   This week's topic is on narcolepsy.


 * THIS WEEK ON NEUROLOGYLIVE® — JUNE 17, 2024
   
   Published Date: 20 Jun 2024
   
   Here's some of what is coming soon to NeurologyLive® this week.


 * FDA GRANTS REGENERATIVE MEDICINE ADVANCED THERAPY DESIGNATION FOR AMT-130
   GENE THERAPY IN HUNTINGTON DISEASE
   
   Published Date: 20 Jun 2024
   
   AMT-130, uniQure’s investigational gene therapy, is the first therapeutic
   candidate to receive regenerative medicine advanced therapy designation for
   Huntington disease.


 * OREXIN AGONIST TAK-861 SHOWS PRONOUNCED EFFECTS IN PHASE 2B TRIAL OF
   NARCOLEPSY TYPE 1
   
   Published Date: 20 Jun 2024
   
   Across both the primary and secondary end points, treatment with TAK-861
   resulted in significant improvements in symptom severity among patients with
   narcolepsy type 1.


 * FDA CLEARS PHASE 1/2 CLINICAL TRIAL FOR SPINOGENIX’S ALS TREATMENT SPG302
   
   Published Date: 20 Jun 2024
   
   The cleared phase 1/2 clinical trial will assess SPG302 as a once-a-day pill
   among patients with amyotrophic lateral sclerosis.


 * PEDIATRIC PALLIATIVE CARE: WHAT THE GENERAL PEDIATRICIAN NEEDS TO KNOW
   
   Published Date: 20 Jun 2024
   
   Get to know the essentials of pediatric palliative care.


 * WEEKLY REVIEW: NEW FDA APPROVALS FOR T2D, PJIA, AND MORE
   
   Published Date: 20 Jun 2024
   
   Get caught up with our journal! Review some of the top stories from the
   Contemporary Pediatrics website over the last week, and catch up on anything
   you may have missed.





WEEKLY REVIEW: NEW FDA APPROVALS FOR T2D, PJIA, AND MORE

Published Date: 20 Jun 2024

Get caught up with our journal! Review some of the top stories from the
Contemporary Pediatrics website over the last week, and catch up on anything you
may have missed.


ONABOTULINUMTOXINA SHOWS PROMISE FOR TREATING CHRONIC MIGRAINE

Published Date: 20 Jun 2024

Approximately half of study participants had tried lifestyle modifications and
used vitamin supplementation, and most were taking multiple medications.


SURVEY: MOST PARENTS BELIEVE SCHOOLS SHOULD HAVE A MENTAL HEALTH PROFESSIONAL

Published Date: 20 Jun 2024

The national survey revealed parents are eager to learn more about school-based
mental health services.


REAL-WORLD EXPERIENCES WITH AFLIBERCEPT 8MG

Published Date: 20 Jun 2024

Experts share their real-world experience with aflibercept 8 mg, comparing it to
its predecessor, aflibercept 2 mg.

View All News


ARTICLES

--------------------------------------------------------------------------------

Gene & Cell Therapy


HOW TO MANAGE OSTEONECROSIS OF THE HIP: INNOVATIVE TREATMENT STRATEGIES

Stem cell therapy is one of the most promising treatments for osteonecrosis of
the hip.

Pharmacology


THE BENEFITS OF ANUSOL HC SUPPOSITORY: A GUIDE TO RELIEF AND COMFORT

Anusol HC Suppository is a medication that is used to treat a variety of
conditions in the rectal area.

Other


UNLOCKING THE POTENTIAL OF PHENIRAMINE: A NEW WAY TO TREAT ALLERGIES

While pheniramine is generally considered to be safe, it can cause some side
effects.

All Speciality


LIVING WITH RAYNAUD'S SYNDROME: HOW TO MANAGE AND OVERCOME THE CHALLENGES

Although there is no cure for Raynaud’s Syndrome, there are treatments available
to help manage the symptoms.



Pharmacology


FRESH BREATH ON THE GO: THE BENEFITS OF NOZIN NASAL SANITIZER

--------------------------------------------------------------------------------

Pharmacology


UNCOVERING THE BENEFITS OF CHLORTHALIDONE: A COMPREHENSIVE GUIDE

--------------------------------------------------------------------------------

Surgery


CLOSED RHINOPLASTY: A REVOLUTIONARY APPROACH TO NOSE RESHAPING

--------------------------------------------------------------------------------

Other


UNVEILING THE MYSTERIES OF ROSEOLA: A CLOSER LOOK AT THE COMMON CHILDHOOD
ILLNESS

--------------------------------------------------------------------------------

Hematology


EVERYTHING YOU NEED TO KNOW ABOUT TRICHELEMMAL CYSTS: SYMPTOMS, CAUSES,
DIAGNOSIS AND TREATMENT

--------------------------------------------------------------------------------

Cardiology


UNLOCKING THE MYSTERIES OF HYPERTENSION: HOW TO CONTROL IT NATURALLY

--------------------------------------------------------------------------------

View All Articles




WEBINARS

--------------------------------------------------------------------------------


MAGNEX - AN ANTIBIOTIC COMBINATION TO TREAT VARIOUS BACTERIAL INFECTIONS

Infedis Health


EXPLORING THE IMPACT OF CDK 4/6 INHIBITORS THROUGH CASE-BASED PANEL DISCUSSION

Dr. Narendra Agarwal and 2 more


NEWER ADVANCES IN THE MANAGEMENT OF ATOPIC DERMATITIS AND ROLE OF PDE4
INHIBITORS

Dr. Anand Nott and 2 more


UNLOCKING THE LIFESTYLE PUZZLE: NAVIGATING LIFESTYLE-RELATED DISORDERS

Dr. Gopinath Menon

View all


QUIZZES

--------------------------------------------------------------------------------

Quiz on Role of Ayurvedic Massage (Abhyanga)

Author Name : Arina M.

Quiz on Microscopic Studies for Diagnosis

Author Name : Arina M.

Quiz on Drug-resistant Tuberculosis Management

Author Name : Arina M.

Quiz on Preventive Care in OPD Settings

Author Name : Arina M.



Bjmc Research Conference

Author Name : Dr. Sadhana



Quiz on Nutrition and Oral Health

Author Name : Arina M.








Fastest Growing Medical Platform for
Doctors.




REACH US

Please contact the below details for any other information

Email:
global@hidocdr.com

Phone Number:
+1(415)463-3094

Address:
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY,
82801


HIDOC DR. FEATURES

Drug Database



Webinars



Drug Interaction



News



Articles



Quizzes



Diseases Database



Surveys

© Copyright 2024 Hidoc Dr. Inc.

Terms & Conditions | Privacy Policy | About Hidoc Dr
Home
Profile
Login
By using this site, you agree with our use of cookies.
Accept Cookies



user-signalWir schätzen Ihre Privatsphäre
Alles ablehnenAlles akzeptieren
ZusammenfassungZwecke1562 Partner
Willigen Sie in diese Aktivitäten zur Verarbeitung personenbezogener Daten durch
uns und unsere Partner ein?

Speichern von oder Zugriff auf Informationen auf einem Endgerät

Genaue Standortdaten und Identifikation durch Scannen von Endgeräten

Personalisierte Werbung und Inhalte, Messung von Werbeleistung und der
Performance von Inhalten, Zielgruppenforschung sowie Entwicklung und
Verbesserung von Angeboten

Einige Partner berufen sich möglicherweise auf ihr berechtigtes Interesse. Sie
können hier Einspruch gegen das berechtigte Interesse des Verkäufers einlegen.
Ihre Auswahl auf dieser Website wird für diese Website angewendet. Sie können
Ihre Einstellungen jederzeit ändern, einschließlich des Widerrufs Ihrer
Zustimmung, indem Sie auf den Link oder das Symbol am unteren Rand dieser Seite
klicken. Bitte beachten Sie, dass Sie möglicherweise nach unten scrollen müssen,
um darauf zuzugreifen. Cookies, IDs, Browserdaten oder ähnliche
Online-Identifikatoren dürfen für einen oder mehrere der hier genannten Zwecke
verarbeitet werden.

Powered By